Company Overview
Jsuru Therapeutix, Inc. is a pioneering biotechnology startup dedicated to developing targeted therapies and diagnostic tools for multi-therapy resistant cancers, with particular focus on pancreatic cancer.
Our Story
Jsuru Therapeutix is a 100% black and woman-owned biotech startup focused on cancer therapies.
Our company’s symbol is the Palanca Negra Gigante (Giant Sable Antelope), Angola’s spirit animal.
Team
Jsuru Therapeutix, Inc. is lead by Founder and Chief Executive Officer, Dr. Nzola De Magalhães, a biomedical scientist and engineer with 30 years of biomedical research and laboratory bench experience.
Dr. Nzola De Magalhães, is an Assistant Adjunct Professor in the department of Surgery, at the University of California Irvine’s (UCI) School of Medicine. Her research foundation is in medical photonics (photomedicine), biomedical imaging, and basic and translational cancer research. She also has expertise, with state certifications, in laser/electro-optics and immunohistotechnology. Prior to pursuing her graduate degrees, she worked professionally as a bench chemist at a nutraceutical company.
